Danaher Corporation (DHR) — Stock Price, Chart & Analysis
Danaher Corporation (DHR) is a Healthcare stock currently trading at $204.76, up 2.39% on the day. It carries a market capitalization of $143.94B and a trailing P/E ratio of 35.61. Over the past 52 weeks, DHR has traded between $160.93 and $242.80. Danaher Corporation pays a dividend yielding 0.8%. View the live DHR chart, technical opinion, analyst ratings, fundamentals and latest news below.
Danaher Corporation (DHR) key data
| Price | $204.76 |
| Change (today) | +2.39% |
| Previous close | $199.98 |
| Market cap | $143.94B |
| P/E ratio (TTM) | 35.61 |
| EPS (TTM) | $5.75 |
| Dividend yield | 0.8% |
| 52-week high | $242.80 |
| 52-week low | $160.93 |
| Beta | 0.80 |
| Avg. volume | 5.16M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Frequently asked questions about Danaher Corporation (DHR)
How much does one share of Danaher Corporation cost?
As of the latest update, one share of Danaher Corporation (DHR) trades at $204.76 (+2.39% today).
What is Danaher Corporation's market cap?
Danaher Corporation has a market capitalization of approximately $143.94B.
What is Danaher Corporation's P/E ratio?
Danaher Corporation has a trailing price-to-earnings (P/E) ratio of 35.61.
What is Danaher Corporation's earnings per share (EPS)?
Danaher Corporation's trailing twelve-month EPS is $5.75.
Does Danaher Corporation pay a dividend?
Yes — Danaher Corporation pays a dividend with a yield of 0.8% ($1.60 per share annually).
What is Danaher Corporation's 52-week trading range?
Over the past year, DHR has traded between $160.93 and $242.80.
What is the analyst price target for Danaher Corporation?
The mean analyst price target for Danaher Corporation is $227.96. This is informational only and not investment advice.
Latest Danaher Corporation (DHR) news
- Here's How ABT Broadens Diagnostics Growth Base With Oncology ExpansionNews · Aug 7, 2026
- [Latest] Global AI In Digital Pathology Market Size/Share Worth USD 5.14 Billion by 2035 at a 18.02% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)News · Aug 5, 2026
- Can Danaher (DHR) Trade At A Discount After Its CEO Change?News · Aug 5, 2026
- How Investors Are Reacting To Danaher (DHR) CEO Transition, Buybacks, And Updated 2026 OutlookNews · Aug 4, 2026
- Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?News · Aug 4, 2026
- Danaher Beat Earnings Estimates, so Why Are Investors Still Concerned About Growth?News · Aug 4, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live DHR dashboard…